Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental diiodohydroxyquinoline poisoning |
Causative agent (attribute) |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Intentional diiodohydroxyquinoline poisoning |
Causative agent (attribute) |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
intoxication par la diiodohydroxyquinoléine d'intention indéterminée |
Causative agent (attribute) |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Diiodohydroxyquinoline 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Iodoquinol+hydrocortisone 1%/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Diiodohydroxyquinoline 210 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Poisoning caused by diiodohydroxyquin (disorder) |
Causative agent (attribute) |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Product containing diiodohydroxyquinoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Product containing diiodohydroxyquinoline and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Accidental diiodohydroxyquinoline poisoning |
Causative agent (attribute) |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Intentional diiodohydroxyquinoline poisoning |
Causative agent (attribute) |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
intoxication par la diiodohydroxyquinoléine d'intention indéterminée |
Causative agent (attribute) |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Poisoning caused by diiodohydroxyquin (disorder) |
Causative agent (attribute) |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Adverse reaction to diiodohydroxyquin |
Causative agent (attribute) |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 650 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 210 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 210 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
|
Diiodohydroxyquinoline 210 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 650 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline and hydrocortisone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Product containing only diiodohydroxyquinoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |
Product containing diiodohydroxyquinoline and hydrocortisone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Diiodohydroxyquinoline |
Inferred relationship |
Some |
1 |